Cargando…
Effects of Primary Mast Cell Disease on Hemostasis and Erythropoiesis
Mast cell disease is an epigenetically and genetically determined disease entity with very diverse clinical manifestations in potentially every system and tissue due to inap pro priate release of variable subsets of mast cell mediators together with accumulation of either morphologically normal or a...
Autores principales: | Seidel, Holger, Hertfelder, Hans-Jörg, Oldenburg, Johannes, Kruppenbacher, Johannes P., Afrin, Lawrence B., Molderings, Gerhard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396658/ https://www.ncbi.nlm.nih.gov/pubmed/34445665 http://dx.doi.org/10.3390/ijms22168960 |
Ejemplares similares
-
Determination of Plasma Heparin Level Improves Identification of Systemic Mast Cell Activation Disease
por: Vysniauskaite, Milda, et al.
Publicado: (2015) -
Case Report: Treatment of systemic mastocytosis with sunitinib
por: Molderings, Gerhard J., et al.
Publicado: (2017) -
A survey of the currently known mast cell mediators with potential relevance for therapy of mast cell-induced symptoms
por: Molderings, Gerhard J., et al.
Publicado: (2023) -
Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options
por: Molderings, Gerhard J, et al.
Publicado: (2011) -
Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome
por: Afrin, Lawrence B., et al.
Publicado: (2020)